MDT Q2 2024 Earnings — Medtronic plc Revenue & Financial Results | Market Cap Arena

MDTMedtronic plc

$116B

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$8.0B+5.3% YoY

Gross Profit

$5.2B65.4% margin

Operating Income

$1.3B16.8% margin

Net Income

$909M11.4% margin

EPS (Diluted)

$0.68

QoQ Revenue Growth

+3.7%

Cash Flow

Operating Cash Flow

$661M

Free Cash Flow

$200M

Stock-Based Comp.

$146M

Balance Sheet

Total Assets

$90.1B

Total Liabilities

$38.4B

Stockholders' Equity

$51.5B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8.0B	$7.6B	+5.3%
Gross Profit	$5.2B	$5.0B	+3.4%
Operating Income	$1.3B	$1.4B	-4.6%
Net Income	$909M	$427M	+112.9%

Revenue Segments

Cardiovascular

$2.9B35%

Neuroscience Group

$2.3B27%

Medical Surgical

$2.1B26%

Diabetes Group

$963M12%

Other

$22M0%

Geographic Segments

UNITED STATES

$4.2B52%

Total Other Countries, Excluding United States and Ireland

$3.8B47%

IRELAND

$29M0%